Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1233257 | 0.80 | GAA (0.33) | GAARAB9AKDM4E | |
| SCHEMBL507708 | 0.69 | — | — | |
| Water SCHEMBL7540447 | 0.67 | — | — | |
| SCHEMBL10403596 | 0.67 | — | — | |
| Ammonia Solution, Strong SCHEMBL7922143 | 0.63 | — | — | |
| SCHEMBL9332955 | 0.61 | — | — | |
| SCHEMBL19594688 | 0.55 | — | — | |
| SCHEMBL2812626 | 0.48 | — | — | |
| SCHEMBL2362493 | 0.35 | KDM4E (0.41) | KDM4E | |
| Hydrazine SCHEMBL15534268 | 0.29 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020058820-A1 | Process for the preparation of highly pure 5,5' -bi-1H-tetrazolediammonium salts | JAPAN HYDRAZINE CO., LTD. | 2002-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058820-A1 | Process for the preparation of highly pure 5,5' -bi-1H-tetrazolediammonium salts | SLC7A1, SLC7A5, AP3M1 | GAA 756/4885RAB9A 1188/4885KDM4E 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.